• No results found

Thrombotic risk

Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach

Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach

... thrombosis risk and the publication of new guidelines by the World Health Organi- zation in 2009 and the Centers for Disease Control and Prevention in 2010 addressing this complex issue have led to ...

13

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant

... cardiovascular risk fac- tors at baseline, such as diabetes and smoking, with an excessively increased risk of thrombosis in our ...higher risk of ...increased thrombotic risk in LA ...

13

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay

Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay

... a risk-stratified ...of thrombotic risk assessment in primary and secondary prevention of venous and arterial thromboembolic disease in patients with APS, focusing on new antibody specificities, ...

9

Does chemoradiotherapy induce thrombotic risk in advanced nasopharyngeal carcinoma

Does chemoradiotherapy induce thrombotic risk in advanced nasopharyngeal carcinoma

... Four patients (WHO Type 2 Stage IV) had significantly elevated D-dimer levels (P<0.01) of mean 597.8 ± 55.0 ng/mL (range between 538 and 669 ng/mL) and reduced platelets (P = 0.02) at post-radiotherapy. There was no ...

5

Anti-JNK2 peptide&ndash;siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

Anti-JNK2 peptide&ndash;siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

... attenuated thrombotic risk, restored endothelial barrier integrity, reduced plaque necrosis, and depleted plaque-macrophage content after only a few weeks; JNK2 inhibition exerted suppression of ...

19

High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden

High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden

... In order to explam the different venous thrombotic nsks in first-degree relatives of probands of selected thrombophilic families and first-degree relatives of unselected patients with th[r] ...

7

Clinico-Demographic Analysis and Outcome of Childhood Thrombosis in a Pediatric Hematology-Oncology Unit: A single Center Experience

Clinico-Demographic Analysis and Outcome of Childhood Thrombosis in a Pediatric Hematology-Oncology Unit: A single Center Experience

... identified risk factors for thrombosis present by ...in thrombotic risk profile between groups of comparable ages [15]; nevertheless, the International Society of Thrombosis and Hemostasis reported ...

10

Original Article Diabetes mellitus-associated hyperglycemia is a risk factor for recurring deep vein thrombosis and post-thrombotic syndrome-a cohort study

Original Article Diabetes mellitus-associated hyperglycemia is a risk factor for recurring deep vein thrombosis and post-thrombotic syndrome-a cohort study

... specific thrombotic risk factors (elder, major surgery, malignant diseases, major trau- ma, cardiovascular and cerebrovascular dis- eases, thrombophilia, HRT and other prothrom- botic diseases, ...

11

Vol 28, No 1 (2015)

Vol 28, No 1 (2015)

... We found that the decision to start an antithrombotic therapy is also influenced by patient’s age, i.e. the use of this therapy increases with ageing (Table 5). However, it is also not possible to establish a ...

10

Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)

Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores)

... the risk of a thrombotic ...consistent risk factor for DVT and for development of CVD, although to a lesser degree than F5 ...for thrombotic risk factors – F5, F2 and MTHFR – in São ...

9

Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome

Clinical evaluation of thrombotic microangiopathy: identification of patients with suspected atypical hemolytic uremic syndrome

... It is more frequent in females, recipients of grafts with a major or bidirectional ABO blood group mismatch. The frequency of transplant-associated TMA correlated with GvHD severity [31]. With the current knowledge that ...

8

Study on etiopathogenesis clinical presentation and outcome in 100 young stroke patients.

Study on etiopathogenesis clinical presentation and outcome in 100 young stroke patients.

... independent risk factor for stroke following ...stroke risk (41). The risk for thromboembolism is also higher among patients in chronic atrial ...

115

Urinary pro thrombotic, anti thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

Urinary pro thrombotic, anti thrombotic, and fibrinolytic molecules as biomarkers of lupus nephritis

... In summary, this is the first systematic study to assess urinary pro-thrombotic molecules, anti-thrombotic mol- ecules, and fibrinolytic molecules as biomarkers of lupus nephritis. Both thrombogenic and ...

10

Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives; a case report

Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives; a case report

... Case Presentation: A daughter and her biological mother were diagnosed with pregnancy-induced thrombotic microangiopathy and anti-glomerular basement membrane glomerulonephritis, respectively. Both developed ...

5

THROMBOTIC THROMBOCYTOPENIC PURPURA

THROMBOTIC THROMBOCYTOPENIC PURPURA

... findings and course of the disease, a clinical diagnosis of thrombotic thrombocytopenic.. purpura was made at this time.[r] ...

17

COPD disease severity and the risk of venous thromboembolic events: a matched case&ndash;control study

COPD disease severity and the risk of venous thromboembolic events: a matched case&ndash;control study

... and over), it is unlikely that any subjects are pregnant. The number of women on hormone replacement therapy is likely to be low, but any distributional differences between cases and controls will possibly be captured by ...

10

Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma

Erythropoiesis-stimulating agents and cardiovascular events in patients with myelodysplastic syndrome and multiple myeloma

... As displayed in Table 2, crude incidence rates of MI and stroke were higher in ESA-treated patients compared with patients without ESA treatment. The crude and adjusted HRs for VTE, MI, and stroke during the total ...

10

Should selective Cox-2 inhibitors be used more?

Should selective Cox-2 inhibitors be used more?

... high risk of cerebrovascular complications, myocardial infarction, and renal dysfunction as compared to the placebo ...The risk of above-mentioned serious adverse events was twofold more in coxibs­ ...

5

Significance of activity and time of occurrence in stroke and evaluation of risk factors

Significance of activity and time of occurrence in stroke and evaluation of risk factors

... the risk factors associated with ...independent risk factor for ...the risk of the stroke reduced by 32% in patients with ...the risk of cardiovascular events ...

105

Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus

Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus

... the risk of thrombotic events in SLE patients ...and thrombotic events, as is also reflected in the present but limited ...the risk of future thrombotic ...the risk of ...

10

Show all 10000 documents...

Related subjects